Nearly 3 in 4 Americans are battling the same exhausting health problem, CDC reveals
Worry about sleep causes more sleep disruption, expert warns Fox News Senior Medical Analyst Dr. Marc Siegel emphasizes not obsessing […]
Health
Some readers love the access patient portals offer. Others despise the technology and information overload.
Some people love them because they have all that information at their fingertips. Which is also why others hate them.
Champion athlete soils herself mid-race and keeps going, prompting fitness competition to change rules
NEWYou can now listen to Fox News articles! A popular global fitness competition is changing its rules after an explosive
Popular drugs for bone health linked to significantly lower Alzheimer’s risk
NEWYou can now listen to Fox News articles! Commonly used osteoporosis drugs were linked to a lower risk of Alzheimer’s
States haven’t yet been able to obtain Covid-19 shots from the CDC, delaying their distribution to millions of children through federal programs, according to people familiar with the matter
The Centers for Disease Control and Prevention hasn’t opened up the ordering process, raising concerns about delays as vaccination programs
Health Care Roundup: Market Talk
Gain insight on AstraZeneca and more in the latest Market talks covering the health care sector. Source link
Rare cancer cases strike in California community as families demand answers
NEWYou can now listen to Fox News articles! A cluster of rare cancer diagnoses has sparked concern and prompted environmental
The “Oreo-gate” saga was fake. The parent-group wars over school snacks is very real.
After a fictional saga over Oreos went viral, parents and teachers admitted the reality of snack politics is even stranger.
Heard on the Street: With the Food and Drug Administration’s hard-liners gone, investors are rushing back into rare-disease bets
With the Food and Drug Administration’s hard-liners gone, investors are rushing back into rare-disease bets. Source link
Legend Biotech is tapping a Novartis executive to run the cell-therapy maker, ending a nearly two-month search that began when former CEO Ying Huang resigned in July
Ingrid Zhang will take the helm of the cancer therapy company, filling a post vacant since its previous CEO abruptly